122.81USD-3.54%Mkt Cap: 10.59B $P/E: —Today
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natu…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap10.59B $
Enterprise Value9.49B $
Revenue (TTM)105.00M $
Gross Profit-270.57M $
Net Income (TTM)-311.35M $
Revenue/Share1.126 USD
Last Price122.81 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees273
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-24.50
PEG—
EV/EBITDA-27.92
EV/Revenue90.38
P/S95.18
P/B6.66
EPS (TTM)-3.10
EPS (Forward)-4.96
52W Range
39.8492% of range130.05
52W High130.05 USD
52W Low39.84 USD
Profitability
Gross Margin-257.69%
Oper. Margin-116.32%
EBITDA Margin0.00%
Profit Margin-794.04%
ROE-19.71%
ROA-17.86%
Growth
Revenue Growth466.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-232.89M $
CapEx (TTM)1.45M $
FCF Margin-137.21%
FCF Yield-1.36%
Net Debt-612.43M $
Net Debt/EBITDA1.80
Balance Sheet
Debt/Equity0.05
Current Ratio10.34
Quick Ratio9.97
Book Value/Sh18.23 USD
Cash/Share8.310 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)130.91 USD
Upside (mean)+6.6%
Target Range111.00 USD – 155.00 USD
$111.00+6.6% to mean$155.00
# Analysts22
Ownership
Shares Out.83.15M
Float66.06M
Insiders2.12%
Institutions117.09%
Short Interest
Short Ratio15.6d
Short % Float15.44%
Short % Out.12.00%
Shares Short9.98M
Short (prev mo.)10.15M
Technical
SMA 50107.90 (+13.8%)
SMA 20085.88 (+43.0%)
Beta1.95
S&P 52W Chg18.16%
Avg Vol (30d)635.08K
Avg Vol (10d)792.85K
Technical Indicators
RSI (14)75.1
MACD3.7767
MACD Signal2.0975
MACD Hist.+1.6793
BB Upper122.80 USD
BB Middle110.00 USD
BB Lower97.21 USD
BB Width23.26%
ATR (14)4.981 USD
Vol Ratio (20d)1.31x